Baby boomers drive cosmeceuticals growth

- Last updated on GMT

Related tags: Skin, Marketing, Us

Demand for cosmeceutical products in the US is expected to increase
8.5 per cent per year to $5.1 billion in 2007, propelled by a
stream of new and advanced age-defying product introductions,
suggests a new report.

Demand for cosmeceutical products in the US is expected to increase 8.5 per cent per year to $5.1 billion in 2007, propelled by a stream of new and advanced age-defying product introductions, suggests a new report from the Freedonia Group.

The value of chemicals used in these appearance-enhancing products is expected to advance over10 per cent per year to $1.4 billion in 2007, with gains spurred by the use of new andhigher value-added active ingredients in product formulations.

The 'Cosmeceuticals' report also reveals that skin care products, including anti-ageing, acne and sun care products, willcontinue to dominate cosmeceutical product demand, accounting for nearly 60per cent of the total in 2007.

But despite this projected healthy annual growth of 7.8 per cent,further gains will be restrained by fierce price competition among the large number ofover-the-counter brands on the market.

Gains will be driven by a highly receptive, fast-expandinggroup of middle-aged consumers who want to prevent or redress visibledamage to the skin caused by ageing, ultraviolet radiation and other environmental factors. Improved formulations and the passage of the relatively affluent baby boomergeneration through middle age will promote the wide use of value-added age-defyingproducts, explains the report.

Professional products are expected to experience the fastest growth amongcosmeceutical products with annual gains exceeding 15 per cent. According to the study, advances willbe led by Merck's finasteride-based hair growth product propecia and Allergan'swrinkle-fighting Botox, both of which enjoy the pricing flexibility of patent protection.

Other cosmeceutical chemicals expected to record double-digit gains includebotanical extracts and enzymes, supported by consumer preferences for naturalproducts and the development of more stable and better performing chemicals at acompetitive price. Above-average growth is also forecast for smaller volume chemicalsincluding coenzyme Q10 and hyaluronic acid dermal fillers.

'Cosmeceuticals' is available from The FreedoniaGroup​.

Related news

Show more

Related products

show more

Faster Skin Firming with Replexium®

Faster Skin Firming with Replexium®

BASF Care Creations, North America | 16-Mar-2020 | Product Brochure

Replexium® is a skin-bioavailable synergistic complex of two patented peptides that delivers firmer skin in 21 days – faster than the market benchmark....

Related suppliers

Follow us

Products

View more

Webinars